Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Concert Pharmaceutic (CNCE)

0 (0%)

Open:

Pre. Close:

High:

Low:

Volume:

Market Cap:

0M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

19.969 - 20.08

20.08 - 20.183

Low:

19.075 - 19.221

19.221 - 19.355

Close:

19.498 - 19.71

19.71 - 19.905

Technical analysis  (as of: 2018-01-22 4:24:28 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 30.54     One year: 35.87

Support:

Support1: 18.77    Support2: 15.62

Resistance:

Resistance1: 26.15    Resistance2: 30.71

Pivot:

24.33

Moving Averages:

MA(5): 19.64     MA(20): 24.66

MA(100): 19.48     MA(250): 16.17

MACD:

MACD(12,26): -1.21     Signal(12,26,9): -0.17

%K %D:

%K(14,3): 9.42     %D(3): 9.48

RSI:

RSI(14): 31.53

52-Week:

High:   Low:   Change(%): 109.9

Average Vol(K):

3-Month: 47485  10-Days 85554

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CNCE has closed above bottom band by 19.5%. Bollinger Bands are 266% wider than normal. The large width of the bands suggest high volatility as compared to CNCE's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 12 Jan 2018 20:19:17 GMT
Why Concert Pharmaceuticals, Inc. Is Singing the Blues Today

Thu, 18 Jan 2018 06:56:15 GMT
Concert Pharmaceuticals Is In A Major Jam: Where To Next?

Fri, 12 Jan 2018 12:00:00 GMT
FDA Grants Fast Track Designation to Concert Pharmaceuticals' CTP-543 for the ...

Mon, 15 Jan 2018 21:07:13 GMT
Concert Pharmaceuticals Plunges on Patent Petition Setback

Tue, 16 Jan 2018 10:41:15 GMT
Concert Pharma shares hit low note on patent challenge denial

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

22.77

Shares Float (M)

21.58

% Held by Insiders

5.20

% Held by Institutions

64.20

Shares Short (K)

663

Shares Short Prior Month (K)

609

Stock Financials

EPS

-2.420

EPS Est. Current Year

-2.180

EPS Est. Next Year

-2.440

EPS Est. Next Quarter

-0.730

Forward EPS

-2.409

Book Value (p.s.)

2.280

PEG Ratio

Profit Margin

70.69

Operating Margin

-69305.47

Return on Assets (ttm)

55.3

Return on Equity (ttm)

61.4

Qtrly Rev. Growth

-34.6

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

4.106

Qtrly Earnings Growth

Operating Cash Flow (M)

98.94

Levered Free Cash Flow (M)

-25.39

atoplab.com

Valuation

P/E

-8.14

P/E Growth Ratio

0.01

P/BV

8.64

P/S

P/CF

4.54

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.